Open AccessS209 A Review of Adverse Drug Reactions for Bevacizumab-awwb and Bevacizumab-bvzr in the Treatment of Metastatic Colorectal Cancer Reported to the FDA Adverse Event Reporting System Database
Author(s) -
Thomas A. Wichelmann,
Sufyan AbdulMujeeb,
Eli D. Ehrenpreis
Publication year - 2021
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000773308.28844.89
Subject(s) - bevacizumab , medicine , biosimilar , colorectal cancer , adverse effect , adverse event reporting system , oncology , database , abdominal pain , cancer , surgery , chemotherapy , computer science